Eight companies from Maryland, Virginia, and Washington, D.C. have been named to TIME’s list of the World’s Top HealthTech ...
Multiply Labs’ $75 million Series B is a bet that robots can make advanced medicines affordable at industrial scale. Arriving ...
CHOP marks a new chapter as Bell retires after nearly 40 years and Mitchell takes the helm. Children’s Hospital of ...
The Institute for In Vitro Sciences (IIVS) has appointed Brenda Braden, SHRM-CP, as Manager, Human Resources. In this role, ...
Secretome Therapeutics, a clinical-stage biotechnology company developing therapies derived from neonatal cardiac progenitor ...
BioBuzz’s Buzzin’ Brood Student Spotlight series celebrates the future of life sciences talent — and the programs, ...
Degrees Pharmaceuticals, a Washington, D.C.-based company developing medicines for vector-borne disease, announced on October ...
The 2026 Philadelphia ORBIE Awards, presented by PhillyCIO and PhillyCISO, part of the Inspire Leadership Network, honored ...
Gilead’s $7.8 billion buyout of Arcellx closed in April. The more durable return may be the operators that deal released into ...
Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s ...
Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results